Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 25;42(2):16312.
doi: 10.36141/svdld.v42i2.16312.

Interstitial lung disease hospitalization patterns between U.S. states from 2016-2020

Eva Ma  1 , Niranjan Jeganathan  2
Affiliations

Interstitial lung disease hospitalization patterns between U.S. states from 2016-2020

Eva Ma et al. Sarcoidosis Vasc Diffuse Lung Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article

Figures

Figure 1.
Figure 1.
Interstitial lung disease-related hospitalizations rates by U.S. States, 2016-2020
Figure 2.
Figure 2.
Average ILD hospitalization rates (per 100,000 persons) (a), hospital length of stay (b), hospital costs (c), and percent routine discharges (d) by states from 2016 to 2020. For states without a reported value, data were unavailable in the NIS database.
Figure 2.
Figure 2.
Average ILD hospitalization rates (per 100,000 persons) (a), hospital length of stay (b), hospital costs (c), and percent routine discharges (d) by states from 2016 to 2020. For states without a reported value, data were unavailable in the NIS database.
See this image and copyright information in PMC

References

    1. Cottin V, Hirani NA, Hotchkin DL, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150) doi: 10.1183/16000617.0076-2018. - PMC - PubMed
    1. Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019;28(151) doi: 10.1183/16000617.0100-2018. - PMC - PubMed
    1. Fan Y, Bender SD, Conoscenti CS, et al. Hospital-based resource use and costs among patients with idiopathic pulmonary fibrosis enrolled in the idiopathic pulmonary fibrosis prospective outcomes (IPF-PRO) registry. Chest. 2020;157(6):1522–30. doi: 10.1016/j.chest.2019.12.041. - PubMed
    1. Frank AL, Kreuter M, Schwarzkopf L. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care. Respir Med. 2019;152:25–31. doi: 10.1016/j.rmed.2019.04.009. - PubMed
    1. Jeganathan N, Sathananthan M. The prevalence and burden of interstitial lung diseases in the USA. ERJ Open Res. 2022;8(1) doi: 10.1183/23120541.00630-2021. - PMC - PubMed

LinkOut - more resources